|
Market Closed -
Bombay S.E.
18:02:31 30/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 29.40 INR | -1.41% |
|
-0.81% | -38.31% |
| Market Cap | 1.04B 10.82M 9.55M 9.04M 8.16M 15.4M 15.58M 108M 41.62M 530M 40.63M 39.74M 1.7B | P/E 2025 |
-22.5x | P/E 2026 | -8.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.3B 13.58M 11.98M 11.34M 10.24M 19.32M 19.55M 136M 52.22M 666M 50.98M 49.86M 2.14B | EV / Sales 2025 |
14.5x | EV / Sales 2026 | 4.45x |
| Free-Float |
25.69% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -1.41% | ||
| 1 week | -0.81% | ||
| Current month | -7.52% | ||
| 1 month | -8.07% | ||
| 3 months | -23.02% | ||
| 6 months | -2.87% | ||
| Current year | -38.31% |
| 1 week | 29.05 |  | 30.78 |
| 1 month | 29.05 | | 33.97 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 60.79 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.41% | -0.81% | -50.67% | -24.62% | 10.96M | |
| -2.33% | -1.12% | +59.27% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +45.77% | +69.98% | 645B | |
| -0.65% | -1.36% | +17.22% | +75.49% | 465B | |
| -2.66% | -3.71% | +84.92% | +41.15% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +2.75% | +53.85% | +56.84% | 229B | |
| -1.47% | -2.37% | +32.35% | +98.89% | 188B | |
| Average | -0.67% | +0.17% | +31.09% | +51.09% | 381.58B | |
| Weighted average by Cap. | -0.33% | +0.30% | +44.68% | +71.39% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 194M 2.03M 1.79M 1.7M 1.53M 2.89M 2.92M 20.3M 7.81M 99.49M 7.62M 7.45M 319M | 279M 2.91M 2.57M 2.43M 2.19M 4.14M 4.19M 29.1M 11.19M 143M 10.93M 10.69M 458M |
| Net income | -108M -1.12M -992K -939K -848K -1.6M -1.62M -11.25M -4.33M -55.13M -4.22M -4.13M -177M | -117M -1.22M -1.08M -1.02M -922K -1.74M -1.76M -12.23M -4.7M -59.94M -4.59M -4.49M -192M |
| Net Debt | 399M 4.16M 3.67M 3.48M 3.14M 5.92M 5.99M 41.63M 16.01M 204M 15.63M 15.29M 655M | 264M 2.76M 2.43M 2.3M 2.08M 3.92M 3.97M 27.56M 10.6M 135M 10.35M 10.12M 434M |
Employees
127
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | ₹29.40 | -1.41% | 2,418 |
| 29/09/26 | ₹29.82 | +0.68% | 4,276 |
| 28/09/26 | ₹29.62 | -2.57% | 2,985 |
| 25/09/26 | ₹30.40 | +2.01% | 2,285 |
| 24/09/26 | ₹29.80 | -1.03% | 1,677 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
